ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

Longmire Reappointed To Cancer Panel

April 8, 1988

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974

Columbia Receives $1 Million ACS Grants

May 3, 1985

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012